7-113878120-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002711.4(PPP1R3A):c.2972G>A(p.Arg991Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,613,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002711.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPP1R3A | NM_002711.4 | c.2972G>A | p.Arg991Lys | missense_variant | 4/4 | ENST00000284601.4 | |
PPP1R3A | XM_005250473.4 | c.2369G>A | p.Arg790Lys | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPP1R3A | ENST00000284601.4 | c.2972G>A | p.Arg991Lys | missense_variant | 4/4 | 1 | NM_002711.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 151958Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000264 AC: 66AN: 250026Hom.: 0 AF XY: 0.000259 AC XY: 35AN XY: 135322
GnomAD4 exome AF: 0.000184 AC: 269AN: 1461290Hom.: 0 Cov.: 31 AF XY: 0.000193 AC XY: 140AN XY: 726956
GnomAD4 genome AF: 0.000191 AC: 29AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74338
ClinVar
Submissions by phenotype
Monogenic diabetes Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Oct 05, 2018 | ACMG criteria: BP4 (REVEL 0.016 + 10 predictors): VUS; evidence thus far indicates digenic inheritance (PPARG) so unable to use frequency data, etc. - |
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PPP1R3A p.Arg991Lys variant was not identified in the literature nor was it identified in ClinVar or LOVD 3.0. The variant was identified in dbSNP (ID: rs374950521) and Cosmic (FATHMM predicted neutra; score=0.09). The variant was identified in control databases in 69 of 281390 chromosomes at a frequency of 0.000245 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 26 of 10348 chromosomes (freq: 0.002513), Other in 4 of 7166 chromosomes (freq: 0.000558), European (non-Finnish) in 33 of 128362 chromosomes (freq: 0.000257), Latino in 4 of 35286 chromosomes (freq: 0.000113), African in 1 of 24622 chromosomes (freq: 0.000041) and South Asian in 1 of 30608 chromosomes (freq: 0.000033); it was not observed in the East Asian and European (Finnish) populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Arg991 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at